Evidence map›Paper›PMID 40897841›Full record

ArticleNature chemistry2025

Magnetic activation of spherical nucleic acids enables the remote control of synthetic cells.

Ellen Parkes, Assala Al Samad, Giacomo Mazzotti, Charlie Newell, Brian Ng, Amy Radford, Michael J Booth

Abstract read
In one paragraph

Article in Nature chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Membrane-Associated Biomolecules for Synthetic Cell Signalling.Chembiochem : a European journal of chemical biology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ellen ParkesDepartment of Chemistry, University of Oxford, Oxford, UK.ORCID 0000-0003-1887-7057
Assala Al SamadDepartment of Chemistry, University College London, London, UK.
Giacomo MazzottiDepartment of Chemistry, University College London, London, UK.
Charlie NewellDepartment of Chemistry, University College London, London, UK.
Brian NgDepartment of Chemistry, University of Oxford, Oxford, UK.
Amy RadfordDepartment of Chemistry, University of Oxford, Oxford, UK.
Michael J BoothDepartment of Chemistry, University of Oxford, Oxford, UK. m.j.booth@ucl.ac.uk.ORCID 0000-0002-4224-798X

Funding

RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/T008709/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/W011468/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/S023828/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/V030434/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/Y032675/1
6 · The paper itself

Abstract

The flexible and modular design of synthetic cells, comprising lipid vesicles capable of imitating the structure and function of living cells, facilitates their application as drug delivery devices. The ability to control the synthesis of biomolecules within synthetic cells using a tissue-penetrating stimulus opens up additional levels of functionality that has the potential to improve biological potency and circumvent drug leakage from preloaded vesicles. To this end, we have designed spherical nucleic acids comprising DNA promoter sequences decorating magnetic nanoparticle cores. These spherical nucleic acids allowed us to harness the heat dissipated from magnetic hyperthermia (a clinically approved anticancer therapy) to regulate cell-free protein synthesis and release cargo on demand. Furthermore, this magnetic regulation of biosynthesis was achieved using clinically tolerable magnetic field strengths and frequencies. We then deployed an opaque blocking material that is impenetrable by current activation methods to highlight the potential of this technology for targeting and controlling the in situ synthesis of biomolecules using tissue-penetrating magnetic fields deep within the body.

Indexed as

Artificial CellsDNAMagnetite NanoparticlesNucleic AcidsDrug Delivery SystemsHumansMagnetic FieldsDNAMagnetite NanoparticlesNucleic Acids

Identifiers

PMID40897841
PMCPMC12491065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.